GBMB Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Inovio Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 11.94 EUR 7.76% Market Closed

Market Cap: €22.6m

I	Inovio Pharmaceuticals Inc F:GBMB	US
G	GAIL (India) Ltd BSE:532155	IN
G	Genworth Financial Inc BMV:GNW	US
M	MDU Resources Group Inc F:MRE	US
	Catena AB F:T9R	SE
S	Shanghai Electric Group Co Ltd XMUN:USR	CN
P	Perenti Global Ltd OTC:AUSDF	AU
H	Heritage Global Inc NASDAQ:HGBL	US
	Nedap NV AEX:NEDAP	NL
A	Abliva AB F:NTP	SE
	Iovance Biotherapeutics Inc NASDAQ:IOVA	US
C	Chart Industries Inc F:I3N	US
A	aTyr Pharma Inc SWB:471A	US
R	Ramaco Resources Inc NASDAQ:METCB	US

Profitability Summary

Inovio Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Low Operating Margin

Negative 3Y Average Operating Margin

-45 463%

Low Net Margin

Negative 3Y Average Net Margin

-44 925%

Healthy Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

-44 203%

Negative ROE

-296%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-638%

ROIC is Increasing

-1 045% > -713%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.